Serina Therapeutics, Inc. (SER) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -4.57M | -6.03M | -3.85M | -3.75M | -4.32M | -4.59M | -2.96M | -8.01M | -1.58M | 121K | -1.02M | -864K |
| Operating CF Margin % | - | - | - | -2884.62% | - | 32778.57% | -21157.14% | - | -31540% | 3.92% | -3531.03% | -12342.86% |
| Operating CF Growth % | -5.69% | -31.47% | -29.98% | 53.18% | -174.06% | -3892.56% | -189.26% | -826.97% | -122.43% | 109.16% | 17.15% | 50.52% |
| Net Income | -6.9M | -3.34M | -4.58M | -6.46M | -4.82M | -2.75M | 1.38M | 5.2M | -9.44M | 1.05M | 1.75M | 808K |
| Depreciation & Amortization | 18K | 24K | 17K | 16K | 17K | 56K | 56K | 57K | 25K | 6K | 53K | 18K |
| Stock-Based Compensation | 1.08M | 948K | 0 | 890K | 956K | 988K | 1.1M | 458K | 53K | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 727K | -2.58M | -678K | 1.1M | -928K | -2.71M | -6.6M | -8.94M | 7.25M | -686K | -2.78M | -1.79M |
| Working Capital Changes | 508K | -1.09M | 1.4M | 706K | 455K | -172K | 1.11M | -4.79M | 535K | -250K | -52K | 105K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 14K | 36K | 0 | 0 | 0 | 0 | -203K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 896K | -811K | 1.04M | 522K | 441K | -949K | 492K | -2.04M | 244K | -130K | 0 | -301K |
| Cash from Investing | -25K | 0 | -13K | -46K | 0 | -5K | -3K | 0 | -14K | -70K | -119K | -315K |
| Capital Expenditures | -25K | 0 | -13K | -46K | 0 | -5K | -3K | 0 | -14K | -70K | -119K | -315K |
| CapEx % of Revenue | - | - | - | 35.38% | - | -35.71% | 21.43% | - | 280% | 2.27% | 410.34% | 4500% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 26.06M | 481K | 6.44M | 5.57M | 4.92M | 5.03M | 86K | 5.37M | 2.73M | -13K | 2K | -11K |
| Debt Issued (Net) | 0 | 0 | 4.91M | 0 | 0 | 109K | 0 | 379K | 2.39M | -13K | -12K | -12K |
| Equity Issued (Net) | 26.06M | 481K | 1.53M | 5.57M | 4.92M | 0 | 0 | 4.99M | 4K | 0 | 14K | 1K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 1K | 4.92M | 86K | 0 | 337K | 0 | 0 | 0 |
| Net Change in Cash | 21.47M | -5.56M | 2.58M | 1.77M | 595K | 437K | -2.88M | -2.64M | 1.14M | 7.22M | 136K | -19K |
| Free Cash Flow | -4.59M | -6.03M | -3.86M | -3.75M | -4.32M | -4.59M | -2.96M | -8.01M | -1.59M | 51K | -1.14M | -1.18M |
| FCF Margin % | - | - | - | -2884.62% | - | 32814.29% | -21178.57% | - | -31820% | 1.65% | -3941.38% | -16842.86% |
| FCF Growth % | -6.27% | -31.32% | -30.29% | 53.18% | -171.65% | -9107.84% | -159.41% | -579.3% | -124.4% | 103.86% | 7.52% | 32.47% |
| FCF per Share | -0.38 | -0.59 | -0.37 | -0.37 | -0.44 | -0.43 | -0.28 | -0.79 | -0.57 | 0.05 | -0.15 | -1.09 |
| FCF Conversion (FCF/Net Income) | 0.66x | 1.81x | 0.84x | 0.58x | 0.90x | 1.67x | -2.10x | -1.54x | 0.11x | 0.12x | -0.58x | -1.07x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |